Prosecution Insights
Last updated: October 04, 2026
Application No. 18/852,162

ANTEGRADE FEMORAL ARTERY ENTRY DEVICE AND SHEATH

Non-Final OA §102
Filed
Sep 27, 2024
Priority
Apr 05, 2022 — provisional 63/327,414 +1 more
Examiner
RODRIGUEZ, CRIS LOIREN
Art Unit
Tech Center
Assignee
The Cooper Health System
OA Round
1 (Non-Final)
26%
Grant Probability
At Risk
1-2
OA Rounds
1y 3m
Est. Remaining
38%
With Interview

Examiner Intelligence

Grants only 26% of cases
26%
Career Allowance Rate
54 granted / 205 resolved
-33.7% vs TC avg
Moderate +11% lift
Without
With
+11.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
28 currently pending
Career history
224
Total Applications
across all art units

Statute-Specific Performance

§101
1.6%
-38.4% vs TC avg
§103
46.4%
+6.4% vs TC avg
§102
24.8%
-15.2% vs TC avg
§112
24.2%
-15.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 205 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 10-12 are rejected under 35 U.S.C. 102(a)(2) as being anticipated by Rogers et al (US 20220401111 A1). Regarding claims 10-12, Rogers discloses a sheath 705 for use with a sheath delivery system, in figures 8a-11f, the sheath 705 [0082-0093] comprising: an elongated lumen with a distal tip 710 and an open proximal end (fig 11c); a curved section located proximal the distal tip such that the curved section does not advance past an entry point into a patient (figs 11c-11d);[0086-0088]; a plurality of suture wings located along the curved section ([0091] wherein a suture wing is configured to receive a suture that fastens the sheath to a skin surface adjacent to the entry point into the patient, such that the curved section of the sheath directs a wire exiting the sheath from the open proximal end away from the patient. The curved section comprises a two- dimensional curve in an x-y plane as in figures 11c-11d. The curved section also comprises a three-dimensional curve along a z-axis as seen in figure 11f. Allowable Subject Matter Claims 1-9 and 13-15 are allowed. The following is a statement of reasons for the indication of allowable subject matter: Regarding claim 1, the art of record does not teach or render obvious a sheath delivery system, comprising a footplate having an axis point about which the footplate pivots, the footplate configured to pivot within the lumen between an initial state that generally lies along the lumen and a rotated state, the footplate anchoring the access device within a blood vessel when the footplate is in the rotated state; a first wire port through which a first wire enters the lumen and advances past the footplate into the blood vessel, so that the first wire advances through the blood vessel in a first direction; and a second wire port configured to guide a second wire into the lumen so that the second wire passes through the lumen such that the second wire advances through the blood vessel in a second direction, in combination with the elements set forth in the claim. Regarding claim 13, the art of record does not teach or render obvious a method of using a sheath delivery system, the method comprising inserting an access device into the blood vessel over the first wire, the access device having a footplate and a depth indicator; receiving an indication from the depth indicator that the access device is sufficiently inserted in the blood vessel to engage the footplate; advancing the first wire through the blood vessel in a first direction; pivoting the footplate so that the footplate is aligned with an antegrade/retrograde axis within the blood vessel, thereby anchoring the access device in the blood vessel; and advancing a second wire through the access device and through a bore in the footplate into the blood vessel in a second direction, in combination with the elements set forth in the claim. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. See PTO-892 form. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Cris L Rodriguez whose telephone number is (571)272-4964. The examiner can normally be reached Monday-Thursday 8am- 2pm.. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Chelsea Stinson can be reached at 571-270-1744. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Cris L. Rodriguez/ Primary Patent Examiner Art Unit 3783
Read full office action

Prosecution Timeline

Sep 27, 2024
Application Filed
Sep 21, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12746380
POWER SUPPLY DEVICE AND MEDICAL DEVICE
3y 9m to grant Granted Sep 29, 2026
Patent 12746592
NEEDLE BENDING DEVICE
3y 6m to grant Granted Sep 29, 2026
Patent 12734308
MEDICAL NEEDLE UNIT WITH AIR FILTER PART FOR PREVENTING AIR INJECTION
3y 2m to grant Granted Sep 15, 2026
Patent 12734289
DRUG DELIVERY DEVICE DRIVE SENSOR
2y 9m to grant Granted Sep 15, 2026
Patent 12728195
DEVICE FOR ADMINISTERING MEDICAL LIQUID, HAVING A HEAT SINK WITH COOLING FINS
3y 9m to grant Granted Sep 08, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
26%
Grant Probability
38%
With Interview (+11.4%)
3y 4m (~1y 3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 205 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month